Clinical Trials · NCT00291772
Continuous Subcutaneous Infusion of Pramlintide and Insulin
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Baylor College of Medicine
- Enrollment
- 13
- Start date
- Jan 2006
- Locations
- 1 site, United States
- Primary endpoint
- Area under the curve for glucose